PA
MDLN

Parallel Advisors’s Medline Inc MDLN Stock Holding History

Parallel Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Sell
4,790
-490
-9% -$19.7K ﹤0.01% 1322
2026
Q1 		$235K Buy
5,280
+4,830
+1,073% +$213K ﹤0.01% 1080
2025
Q4 		$18.9K Buy
+450
New +$19K ﹤0.01% 2322

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors's MDLN Position: Q2 2026 in Review

Parallel Advisors reduced its Medline Inc (MDLN) stake by 9.3% in Q2 2026, selling an estimated $19.7K and leaving 4,790 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Parallel Advisors first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $235K in Q1 2026. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Parallel Advisors held 4,790 shares of Medline Inc worth $189K as of Q2 2026.
  • Parallel Advisors sold 490 Medline Inc shares in Q2 2026, an estimated $19.7K.
  • Medline Inc made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1322 holding.
  • Parallel Advisors first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Parallel Advisors's Medline Inc position peaked at $235K in Q1 2026.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.